Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.22.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net loss $ (13,141) $ (9,879)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 161 179
Amortization of right-of-use assets 168 143
Unrealized loss on investment 10 3
Share-based compensation expense 702 355
Changes in operating assets and liabilities:    
Trade and other receivables 47 21
Other assets 609 377
Trade and other payables 512 1,214
Accrued employee benefits 28 55
Lease liabilities (140) (143)
Net cash used in operating activities (11,044) (7,675)
Cash flows from investing activities:    
Purchases of property and equipment 0 (362)
Net cash used in investing activities 0 (362)
Cash flows from financing activities:    
Proceeds from issues of shares and pre-funded warrants 0 11,497
Shares and pre-funded warrant issuance costs 0 (1,643)
Net cash provided by financing activities 0 9,854
Effects of exchange rate changes on cash and cash equivalents (95) 370
Net increase (decrease) in cash and cash equivalents (11,139) 2,187
Cash and cash equivalents, beginning of period 19,769 9,801
Cash and cash equivalents, end of period 8,630 11,988
Supplemental disclosure of cash flow information:    
Re-measurement of operating lease right-of-use assets and liabilities $ 794 $ 0